Printer Friendly
The Free Library
14,537,391 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Apogent Technologies Inc. Announces Offering of Senior Convertible Contingent Debt Securities --CODES--.


Business/Technology Editors & Health/Medical Writers

BioWire2k

PORTSMOUTH, N.H.--(BW HealthWire)--Oct. 3, 2001

Apogent Technologies Inc. (NYSE NYSE

See: New York Stock Exchange
: AOT AOT Agency of Transportation (Vermont, USA)
AOT Ahead-of-Time
AOT Assisted Outpatient Treatment
AOT Aerosol Optical Thickness
AOT All of Them (band)
AOT As Opposed To
AOT Among Other Things
), a leading manufacturer of clinical diagnostics and life science instruments and consumables, announced today its intention, subject to market and other conditions, to raise approximately $200 million, through a private offering of senior convertible contingent debt securities (CODES(sm)) due 2021 to certain qualified institutional investors qualified institutional investor

An institutional investor that is permitted by the Securities and Exchange Commission to trade private placement securities without registering the securities with the SEC.
. In addition, Apogent has granted the initial purchasers of the CODES an option to purchase up to an additional $40 million of CODES. Apogent's obligations will be guaranteed by certain of its U.S. subsidiaries.

Apogent will use the net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 from the sale of the CODES offered to repay or retire outstanding indebtedness and for other general corporate purposes.

The CODES, the guarantees and the common stock issuable upon conversion of the CODES have not been registered under the Securities Act of 1933, as amended, or applicable state securities laws, and are being offered only to qualified institutional buyers in reliance on Rule 144A Rule 144A

A Securities & Exchange Commission rule modifying a two-year holding period requirement on privately placed securities to permit qualified institutional buyers to trade these positions among themselves.
 under the Securities Act. Unless so registered, the CODES, the guarantees and the common stock issued upon conversion of the CODES may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.

This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities. Any offer of the securities will be made only by means of a private offering memorandum Offering Memorandum

A legal document stating the objectives, risks, and terms of investment involved with a private placement.

Notes:
The private placement of hedge funds necessitates the issue of memorandums.
 to qualified institutional buyers.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 3, 2001
Words:260
Previous Article:Unitil/FG&E Electric Default Service Rate to Decrease by 45%.
Next Article:U.S., Major European Economies Likely to Slip Into `Shallow' Recession in 2001, Merrill Lynch Global Economist Says.



Related Articles
Apogent Technologies Inc. Announces Completion of Senior Convertible Contingent Debt Securities Offering -CODES-.
Favorable Rev. Rul. on contingent convertible bonds.
Apogent Announces Offering of Floating Rate Senior Convertible Debt Securities.
Apogent Announces Pricing of Floating Rate Senior Convertible Debt Securities.
Apogent Announces Sale of Floating Rate Senior Convertible Contingent Debt Securities - CODES.
Fisher Scientific and Apogent Give Notices of Conversion Right.
Fisher Scientific and Apogent Extend Exchange Offers.
Fisher Scientific and Apogent Extend Exchange Offers and Increase Exchange Fees.
Fisher Scientific Announces Results of Apogent Exchange Offers.
Apogent to Redeem $299.8 Million of Its 2.25 Percent Notes.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles